Stay Curious. Stay Connected.
MailNewsletters♡Donate Now
Sign up
*Password must be at least 8 characters and contain one uppercase letter, one lowercase letter, one number and one symbol.
Already have an account?
By submitting, you consent that you are at least 18 years of age and to receive information about MPR's or APMG entities' programs and offerings. The personally identifying information you provide will not be sold, shared, or used for purposes other than to communicate with you about MPR, APMG entities, and its sponsors. You may opt-out at any time clicking the unsubscribe link at the bottom of any email communication. View our Privacy Policy.
Sign in to your profile
Forgot Password?
New to MPR News?
Welcome back
to news
for you
Reset Password

Enter the username on file and we'll send you a code to reset your password.

Still require assistance or not sure what your User Name is?
Welcome back
to news
for you
Email Verification

A verification code has been emailed to

Still awaiting the code?
Martin Moylan
ST. PAUL, Minn.

Medtech group welcomes faster FDA reviews

Go Deeper.

Create an account or log in to save stories.

Like this?

Thanks for liking this story! We have added it to a list of your favorite stories.

Minnesota's medical device industry is welcoming a Food and Drug Administration report saying the agency is speeding up the review of new products.

The agency says the speed and predictability of device reviews have improved for the first time in almost a decade. The FDA says the backlog of devices waiting more than 90 work-days for a decision has dropped by almost two-thirds since 2010.

Shaye Mandle, a spokesman for Minnesota's med-tech industry group, LifeScience Alley, said the FDA report is encouraging.

"The FDA is making progress in the right direction. And we're certainly excited about that," Mandle said. "We've certainly got a long way to go. But we think this is a positive sign."

The FDA says more expedient reviews of medical devices will allow safe and effective devices to come to market faster and cheaper. The agency also says speedier reviews should facilitate innovation, especially by start-up companies needing venture capital to fund development of new technologies.